A retrospective, multicentre study on the efficacy, durability, and tolerability of bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) for the treatment of HIV in a real-world setting in Belgium

R. Nasreddine; E. Florence; J. Yombi; S. Henrard; G. Darcis; J. Van Praet; L. Vandekerckhove; S. Allard; R. Demeester; P. Messiaen; N. Ausselet; M. Delforge; S. De Wit

doi:10.1002/jia2.26009

A retrospective, multicentre study on the efficacy, durability, and tolerability of bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) for the treatment of HIV in a real-world setting in Belgium

R. Nasreddine
, E. Florence
, J. Yombi
, S. Henrard
, G. Darcis
, J. Van Praet
, L. Vandekerckhove
, S. Allard
, R. Demeester
, P. Messiaen
, N. Ausselet
, M. Delforge
, S. De Wit

Research output: Contribution to journal › Meeting abstract in journal

Original language	English
Article number	P122
Journal	Journal of the International AIDS Society
Volume	25
Issue number	S6
Pages (from-to)	116-117
Number of pages	2
ISSN	1758-2652
DOIs	https://doi.org/10.1002/jia2.26009
Publication status	Published - 2022

Access to Document

10.1002/jia2.26009Licence: CC BY

Cite this

Nasreddine, R., Florence, E., Yombi, J., Henrard, S., Darcis, G., Van Praet, J., Vandekerckhove, L., Allard, S., Demeester, R., Messiaen, P., Ausselet, N., Delforge, M., & De Wit, S. (2022). A retrospective, multicentre study on the efficacy, durability, and tolerability of bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) for the treatment of HIV in a real-world setting in Belgium. Journal of the International AIDS Society, 25(S6), 116-117. Article P122. https://doi.org/10.1002/jia2.26009

@article{20b8a964e6c84e20bedb552f0aa13b9c,

title = "A retrospective, multicentre study on the efficacy, durability, and tolerability of bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) for the treatment of HIV in a real-world setting in Belgium",

author = "R. Nasreddine and E. Florence and J. Yombi and S. Henrard and G. Darcis and \{Van Praet\}, J. and L. Vandekerckhove and S. Allard and R. Demeester and P. Messiaen and N. Ausselet and M. Delforge and \{De Wit\}, S.",

year = "2022",

doi = "10.1002/jia2.26009",

language = "English",

volume = "25",

pages = "116--117",

journal = "Journal of the International AIDS Society",

issn = "1758-2652",

publisher = "John Wiley \& Sons",

number = "S6",

}

Nasreddine, R, Florence, E, Yombi, J, Henrard, S, Darcis, G, Van Praet, J, Vandekerckhove, L, Allard, S, Demeester, R, Messiaen, P, Ausselet, N, Delforge, M & De Wit, S 2022, 'A retrospective, multicentre study on the efficacy, durability, and tolerability of bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) for the treatment of HIV in a real-world setting in Belgium', Journal of the International AIDS Society, vol. 25, no. S6, P122, pp. 116-117. https://doi.org/10.1002/jia2.26009

A retrospective, multicentre study on the efficacy, durability, and tolerability of bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) for the treatment of HIV in a real-world setting in Belgium. / Nasreddine, R.; Florence, E.; Yombi, J. et al.
In: Journal of the International AIDS Society, Vol. 25, No. S6, P122, 2022, p. 116-117.

Research output: Contribution to journal › Meeting abstract in journal

TY - JOUR

T1 - A retrospective, multicentre study on the efficacy, durability, and tolerability of bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) for the treatment of HIV in a real-world setting in Belgium

AU - Nasreddine, R.

AU - Florence, E.

AU - Yombi, J.

AU - Henrard, S.

AU - Darcis, G.

AU - Van Praet, J.

AU - Vandekerckhove, L.

AU - Allard, S.

AU - Demeester, R.

AU - Messiaen, P.

AU - Ausselet, N.

AU - Delforge, M.

AU - De Wit, S.

PY - 2022

Y1 - 2022

UR - https://www.webofscience.com/wos/woscc/full-record/WOS:000870695800142

U2 - 10.1002/jia2.26009

DO - 10.1002/jia2.26009

M3 - Meeting abstract in journal

SN - 1758-2652

VL - 25

SP - 116

EP - 117

JO - Journal of the International AIDS Society

JF - Journal of the International AIDS Society

IS - S6

M1 - P122

ER -

Nasreddine R, Florence E, Yombi J, Henrard S, Darcis G, Van Praet J et al. A retrospective, multicentre study on the efficacy, durability, and tolerability of bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) for the treatment of HIV in a real-world setting in Belgium. Journal of the International AIDS Society. 2022;25(S6):116-117. P122. doi: 10.1002/jia2.26009

A retrospective, multicentre study on the efficacy, durability, and tolerability of bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) for the treatment of HIV in a real-world setting in Belgium

Access to Document

Other files and links

Cite this